相关实验视频

Updated: Mar 2, 2026

Chondrogenic Differentiation Induction of Adipose-derived Stem Cells by Centrifugal Gravity

Chondrogenic Differentiation Induction of Adipose-derived Stem Cells by Centrifugal Gravity

Published on: February 24, 2017

骨髓 stromal 细胞通过mTOR 信号增强胆细胞功能和自

Ye Yang¹, Zhijun Zheng²

¹Department of Orthodontics, Guiyang Hospital of Stomatology, 253 Jiefang Road, Nanming District, Guiyang, 550002, Guizhou, China.

Scientific reports

|March 1, 2026

概括

骨髓 stromal 细胞 (BMSCs) 在关节骨关节炎 (TMJOA) 中显示出治疗潜力. BMSCs增强了冠状细胞的增殖,骨质分化和自,这表明mTOR途径针对TMJOA治疗.

科学领域:

细胞生物学细胞生物学
再生医学是一种再生医学.
骨关节炎研究骨关节炎研究

背景情况:

关节骨关节炎 (TMJOA) 是一种退行性关节疾病,治疗选择有限.
骨髓 stromal 细胞 (BMSCs) 正在研究它们的再生和免疫调节特性.
了解BMSC与冠状细胞的相互作用对于开发有效的TMJOA疗法至关重要.

研究的目的:

评估TMJOA中BMSCs的治疗潜力.
研究BMSCs对状冠状细胞增殖,骨质分化和自的作用.
探索mTOR信号通路在BMSC介导效应中的作用.

主要方法:

BMSCs被培养并以表面抗原表达 (CD54,CD90,CD34,CD45) 为特征.
使用阿利沙林红色和油红色O染色,评估了骨质生成和脂肪生成差异化潜力.
进行了与状状红细胞的共同培养实验,分析了增殖,分化和自标志物 (ATG5,Beclin-1,LC3-II,mTOR酸化).
使用拉巴素和SPQ调节mTOR通路,以确认其作用.

主要成果:

在BMSC中,表现出特有的表面标记和差异化潜力.
与BMSC共同培养显著增强了状冠状细胞的增殖和骨质分化.
BMSCs促进了冠状细胞自,由增加的ATG5,Beclin-1和LC3-II表达和减少的mTOR酸化证明.
mTOR通路的抑制/激活证实了其参与BMSC诱导的自.

结论:

BMSCs通过促进状细胞的增殖,骨质分化和自,显示出对TMJOA的显著治疗潜力.
针对mTOR途径是TMJOA的一个有前途的治疗策略.
需要进一步的体内研究来验证这些发现并评估长期结果.

更多相关视频

Chondrogenic Pellet Formation from Cord Blood-derived Induced Pluripotent Stem Cells

Chondrogenic Pellet Formation from Cord Blood-derived Induced Pluripotent Stem Cells

Published on: June 19, 2017

A RANKL-based Osteoclast Culture Assay of Mouse Bone Marrow to Investigate the Role of mTORC1 in Osteoclast Formation

A RANKL-based Osteoclast Culture Assay of Mouse Bone Marrow to Investigate the Role of mTORC1 in Osteoclast Formation

Published on: March 15, 2018

相关概念视频

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

Mesenchymal Stem Cells

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...

PI3K/mTOR/AKT Signaling Pathway

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...

Regulation of Hematopoietic Stem Cells

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...